Homogeneity and High Concordance of ALK Translocation in Primary Lung Adenocarcinoma and Paired Lymph Node Metastasis

被引:8
作者
Ma, Wei
Guo, Lei
Shan, Ling
Liu, Xiuyun
Lyu, Ning [1 ]
Ying, Jianming [1 ]
机构
[1] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Pathol, Beijing, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
中国国家自然科学基金;
关键词
EGFR MUTATION; GENE REARRANGEMENT; FUSION GENE; CANCER; HETEROGENEITY; CRIZOTINIB; IHC; CLASSIFICATION; ASSOCIATION; PROTEIN;
D O I
10.1038/s41598-017-11453-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Translocation of anaplastic lymphoma kinase (ALK) gene is an important determinator for the response to ALK tyrosine kinase inhibitor (TKI) in non-small-cell lung cancer (NSCLC) patients. The existence of genetic heterogeneity will affect the results of molecular testing, especially in biopsy samples from primary or metastatic sites of patients with advanced stage NSCLC. We intended to explore the heterogeneity of ALK gene translocation in excision specimens and to examine the existence of discordance of ALK status between primary tumours and corresponding lymph node metastases. A total of 106 ALK positive lung adenocarcinoma cases were collected for assessment of intratumour heterogeneity of ALK gene translocation, which were stained by the fully automated Ventana ALK D5F3 immunohistochemistry (IHC) analysis. In addition, the ALK gene translocations were evaluated in a series of 53 primary tumours and their paired lymph node metastases using ALK D5F3 IHC staining. The concordance rate between primary tumours and paired metastatic lymph nodes was 100%. ALK status was homogeneous in lung adenocarcinoma samples and was generally stable during metastasis. Therefore, ALK gene translocation can be measured reliably in material from either primary or metastatic tumours in lung adenocarcinoma patients.
引用
收藏
页数:8
相关论文
共 41 条
  • [1] Heterogeneity of Anaplastic Lymphoma Kinase Gene Rearrangement in Non-Small-Cell Lung Carcinomas A Comparative Study Between Small Biopsy and Excision Samples
    Abe, Hideyuki
    Kawahara, Akihiko
    Azuma, Koichi
    Taira, Tomoki
    Takase, Yorihiko
    Fukumitsu, Chihiro
    Murata, Kazuya
    Yamaguchi, Tomohiko
    Akiba, Jun
    Ishii, Hidenobu
    Okamoto, Isamu
    Hoshino, Tomoaki
    Takamori, Shinzou
    Kage, Masayoshi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (05) : 800 - 805
  • [2] Genetic variegation of clonal architecture and propagating cells in leukaemia
    Anderson, Kristina
    Lutz, Christoph
    van Delft, Frederik W.
    Bateman, Caroline M.
    Guo, Yanping
    Colman, Susan M.
    Kempski, Helena
    Moorman, Anthony V.
    Titley, Ian
    Swansbury, John
    Kearney, Lyndal
    Enver, Tariq
    Greaves, Mel
    [J]. NATURE, 2011, 469 (7330) : 356 - +
  • [3] [Anonymous], ONCOTARGET
  • [4] Concomitant EGFR mutation and ALK rearrangement in lung adenocarcinoma is more frequent than expected: Report of a case and review of the literature with demonstration of genes alteration into the same tumor cells
    Baldi, Licia
    Mengoli, Maria Cecilia
    Bisagni, Alessandra
    Banzi, Maria Chiara
    Boni, Corrado
    Rossi, Giulio
    [J]. LUNG CANCER, 2014, 86 (02) : 291 - 295
  • [5] Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
    Cai, Weijing
    Lin, Dongmei
    Wu, Chunyan
    Li, Xuefei
    Zhao, Chao
    Zheng, Limou
    Chuai, Shannon
    Fei, Ke
    Zhou, Caicun
    Hirsch, Fred R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3701 - +
  • [6] Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization-positive nonsmall cell lung cancer
    Camidge, D. Ross
    Theodoro, Mariana
    Maxson, DeLee A.
    Skokan, Margaret
    O'Brien, Tara
    Lu, Xian
    Doebele, Robert C.
    Baron, Anna E.
    Varella-Garcia, Marileila
    [J]. CANCER, 2012, 118 (18) : 4486 - 4494
  • [7] Long-Term Response to Gefitinib and Crizotinib in Lung Adenocarcinoma Harboring Both Epidermal Growth Factor Receptor Mutation and EML4-ALK Fusion Gene
    Chiari, Rita
    Duranti, Simona
    Ludovini, Vienna
    Bellezza, Guido
    Pireddu, Anjuta
    Minotti, Vincenzo
    Bennati, Chiara
    Crino, Lucio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) : E30 - E32
  • [8] Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
    Cui, J. Jean
    Tran-Dube, Michelle
    Shen, Hong
    Nambu, Mitchell
    Kung, Pei-Pei
    Pairish, Mason
    Jia, Lei
    Meng, Jerry
    Funk, Lee
    Botrous, Iriny
    McTigue, Michele
    Grodsky, Neil
    Ryan, Kevin
    Padrique, Ellen
    Alton, Gordon
    Timofeevski, Sergei
    Yamazaki, Shinji
    Li, Quhua
    Zou, Helen
    Christensen, James
    Mroczkowski, Barbara
    Bender, Steve
    Kania, Robert S.
    Edwards, Martin P.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (18) : 6342 - 6363
  • [9] Crizotinib: In locally advanced or metastatic non-small cell lung cancer
    Monique P. Curran
    [J]. Drugs, 2012, 72 (1) : 99 - 107
  • [10] Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
    de Bruin, Elza C.
    McGranahan, Nicholas
    Mitter, Richard
    Salm, Max
    Wedge, David C.
    Yates, Lucy
    Jamal-Hanjani, Mariam
    Shafi, Seema
    Murugaesu, Nirupa
    Rowan, Andrew J.
    Groenroos, Eva
    Muhammad, Madiha A.
    Horswell, Stuart
    Gerlinger, Marco
    Varela, Ignacio
    Jones, David
    Marshall, John
    Voet, Thierry
    Van Loo, Peter
    Rassl, Doris M.
    Rintoul, Robert C.
    Janes, Sam M.
    Lee, Siow-Ming
    Forster, Martin
    Ahmad, Tanya
    Lawrence, David
    Falzon, Mary
    Capitanio, Arrigo
    Harkins, Timothy T.
    Lee, Clarence C.
    Tom, Warren
    Teefe, Enock
    Chen, Shann-Ching
    Begum, Sharmin
    Rabinowitz, Adam
    Phillimore, Benjamin
    Spencer-Dene, Bradley
    Stamp, Gordon
    Szallasi, Zoltan
    Matthews, Nik
    Stewart, Aengus
    Campbell, Peter
    Swanton, Charles
    [J]. SCIENCE, 2014, 346 (6206) : 251 - 256